Your browser doesn't support javascript.
loading
HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis.
Sargsyan, Ashot; Doridot, Ludivine; Hannou, Sarah A; Tong, Wenxin; Srinivasan, Harini; Ivison, Rachael; Monn, Ruby; Kou, Henry H; Haldeman, Jonathan M; Arlotto, Michelle; White, Phillip J; Grimsrud, Paul A; Astapova, Inna; Tsai, Linus T; Herman, Mark A.
Afiliação
  • Sargsyan A; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Doridot L; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Hannou SA; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Tong W; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Srinivasan H; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Ivison R; Harvard Medical School, Boston, Massachusetts, USA.
  • Monn R; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.
  • Kou HH; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Haldeman JM; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Arlotto M; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • White PJ; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Grimsrud PA; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Astapova I; Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, and.
  • Tsai LT; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, USA.
  • Herman MA; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
JCI Insight ; 8(1)2023 01 10.
Article em En | MEDLINE | ID: mdl-36413406
ABSTRACT
Carbohydrate response element-binding protein (ChREBP) is a carbohydrate-sensing transcription factor that regulates both adaptive and maladaptive genomic responses in coordination of systemic fuel homeostasis. Genetic variants in the ChREBP locus associate with diverse metabolic traits in humans, including circulating lipids. To identify novel ChREBP-regulated hepatokines that contribute to its systemic metabolic effects, we integrated ChREBP ChIP-Seq analysis in mouse liver with human genetic and genomic data for lipid traits and identified hepatocyte growth factor activator (HGFAC) as a promising ChREBP-regulated candidate in mice and humans. HGFAC is a protease that activates the pleiotropic hormone hepatocyte growth factor. We demonstrate that HGFAC-KO mice had phenotypes concordant with putative loss-of-function variants in human HGFAC. Moreover, in gain- and loss-of-function genetic mouse models, we demonstrate that HGFAC enhanced lipid and glucose homeostasis, which may be mediated in part through actions to activate hepatic PPARγ activity. Together, our studies show that ChREBP mediated an adaptive response to overnutrition via activation of HGFAC in the liver to preserve glucose and lipid homeostasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Glucose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Glucose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos